1. Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.
Google Scholar | Crossref | Medline | ISI2. Lam, CS, Solomon, SD. Fussing over the middle child: heart failure with mid-range ejection fraction. Circulation 2017; 135: 1279–1280.
Google Scholar | Crossref | Medline3. Lam, CS, Solomon, SD. The middle child in heart failure: heart failure with mid-range ejection fraction (40–50%). Eur J Heart Fail 2014; 16: 1049–1055.
Google Scholar | Crossref | Medline4. Rickenbacher, P, Kaufmann, BA, Maeder, MT, et al. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017; 19: 1586–1596.
Google Scholar | Crossref | Medline5. Hsu, JJ, Ziaeian, B, Fonarow, GC. Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions. JACC Heart Fail 2017; 5: 763–771.
Google Scholar | Crossref | Medline | ISI6. Choi, KH, Choi, JO, Jeon, ES, et al. Guideline-directed medical therapy for patients with heart failure with midrange ejection fraction: a patient-pooled analysis from the Kor HF and Kor AHF Registries. J Am Heart Assoc 2018; 7: e009806.
Google Scholar | Crossref | Medline7. Rastogi, A, Novak, E, Platts, AE, et al. Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1597–1605.
Google Scholar | Crossref | Medline8. Nadruz, W, West, E, Santos, M, et al. Heart failure and midrange ejection fraction: implications of recovered ejection fraction for exercise tolerance and outcomes. Circ Heart Fail 2016; 9: e002826.
Google Scholar | Crossref | Medline9. Triposkiadis, F, Butler, J, Abboud, FM, et al. The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J 2019; 40: 2155–2163.
Google Scholar | Crossref | Medline10. Lupón, J, Gavidia-Bovadilla, G, Ferrer, E, et al. Dynamic trajectories of left ventricular ejection fraction in heart failure. J Am Coll Cardiol 2018; 72: 591–601.
Google Scholar | Crossref | Medline11. Punnoose, LR, Givertz, MM, Lewis, EF, et al. Heart failure with recovered ejection fraction: a distinct clinical entity. J Cardiac Fail 2011; 17: 527–532.
Google Scholar | Crossref | Medline | ISI12. Nadar, SK, Tariq, O. What is heart failure with mid-range ejection fraction? A new subgroup of patients with heart failure. Cardiac Fail Rev 2018; 4: 6–8.
Google Scholar | Crossref | Medline13. Koh, AS, Tay, WT, Teng, THK, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1624–1634.
Google Scholar | Crossref | Medline14. Ibrahim, NE, Song, Y, Cannon, CP, et al. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry. ESC Heart Fail 2019; 6: 784–792.
Google Scholar | Crossref | Medline15. Tsuji, K, Sakata, Y, Nochioka, K, et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail 2017; 19: 1258–1269.
Google Scholar | Crossref | Medline16. Chioncel, O, Lainscak, M, Seferovic, PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-term Registry. Eur J Heart Fail 2017; 19: 1574–1585.
Google Scholar | Crossref | Medline17. Park, CS, Park, JJ, Mebazaa, A, et al. Characteristics, outcomes, and treatment of heart failure with improved ejection fraction. J Am Heart Assoc 2019; 8: e011077.
Google Scholar | Crossref | Medline18. O’Neill, JO, Young, JB, Pothier, CE, et al. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 2005; 111: 2313–2318.
Google Scholar | Crossref | Medline | ISI19. Gitt, AK, Wasserman, K, Kilkowski, C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106: 3079–3084.
Google Scholar | Crossref | Medline | ISI20. Corrà, U, Agostoni, PG, Anker, SD, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology [published correction appears in Eur J Heart Fail 2018; 20: 1501]. Eur J Heart Fail 2018; 20: 3–15.
Google Scholar | Medline21. Agostoni, P, Corrà, U, Cattadori, G, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710–2718.
Google Scholar | Crossref | Medline | ISI22. Aaronson, KD, Schwartz, JS, Chen, TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660–2667.
Google Scholar | Crossref | Medline | ISI23. Corrà, U, Agostoni, P, Giordano, A, et al. The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. Int J Cardiol 2016; 203: 1067–1072.
Google Scholar | Crossref | Medline | ISI24. Agostoni, P, Paolillo, S, Mapelli, M, et al. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail 2018; 20: 700–710.
Google Scholar | Crossref | Medline25. Nadruz, W, West, E, Sengeløv, M, et al. Prognostic value of cardiopulmonary exercise testing in heart failure with reduced, midrange, and preserved ejection fraction. J Am Heart Assoc 2017; 6: e006000.
Google Scholar | Crossref | Medline26. Sato, T, Yoshihisa, A, Kanno, Y, et al. Cardiopulmonary exercise testing as prognostic indicators: comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol 2017; 24: 1979–1987.
Google Scholar | SAGE Journals | ISI27. Popovic, D, Arena, R, Guazzi, M. A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction. Eur J Heart Fail 2018; 20: 1115–1124.
Google Scholar | Crossref | Medline28. Rovai, S, Corrà, U, Piepoli, M, et al. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction. Eur J Heart Fail 2019; 21: 1586–1595.
Google Scholar | Crossref | Medline29. Magrì, D, Piepoli, M, Corrà, U, et al. Cardiovascular death risk in recovered mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test. J Card Fail. Epub ahead of print 17 May 2020. DOI: 10.1016/j.cardfail.2020.04.021.
Google Scholar30. Magrì, D. Peak oxygen uptake in heart failure: Look behind the number! Eur J Prev Cardiol 2018; 25: 1934–1936.
Google Scholar | SAGE Journals | ISI31. Salvioni, E, Corrà, U, Piepoli, M, et al. Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction. ESC Heart Fail 2020; 7: 371–380.
Google Scholar | Medline32. Bussotti, M, Apostolo, A, Andreini, D, et al. Cardiopulmonary evidence of exercise-induced silent ischaemia. Eur J Cardiovasc Prev Rehabil 2006; 13: 249–253.
Google Scholar | SAGE Journals